ClinicalTrials.Veeva

Menu

Visual Performance of Dailies Total1 Multifocal and Acuvue Oasys Max 1-Day Multifocal in Presbyopic Lens Wearers (GIRAFFE)

U

University of Waterloo

Status

Completed

Conditions

Presbyopia

Treatments

Device: Senofilcon A (multifocal)
Device: Deleficon A (multifocal)

Study type

Interventional

Funder types

Other
Industry

Identifiers

Details and patient eligibility

About

The purpose of this study is to measure the logMAR visual acuity when presbyopic soft lens wearers are fit with Dailies Total1 Multifocal and ACUVUE OASYS MAX 1-DAY Multifocal.

Enrollment

28 patients

Sex

All

Ages

42+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  1. Are at least 42 years of age and has full legal capacity to volunteer;
  2. Have signed an information consent letter;
  3. Are willing and able to follow instructions and maintain the appointment schedule;
  4. Habitually wears soft contact lenses for the past 3 months (minimum);
  5. Are presbyopic and require a reading addition of at least +0.75D and no more than +1.75D;
  6. Can be refracted and achieve monocular spectacle distance vision of at least 20/25 Snellen (or +0.10logMAR) visual acuity;
  7. Have contact lens power requirements that fall within the available study lens parameters (distance sphere: +6D to -9D; near addition as per each lens design);
  8. Can be fit with the initial fitting guidelines provided by the lens manufacturer and use either Low or Medium Add (same add in both eyes).

Exclusion criteria

  1. Are a current habitual wearer of Dailies Total1 Multifocal or ACUVUE OASYS MAX 1-DAY Multifocal;
  2. Has refractive astigmatism higher than -0.75DC in either eye;
  3. Are participating in any concurrent clinical or research study involving intervention or invasive ocular tests;
  4. Have any known active ocular disease and/or infection;
  5. Has a systemic condition that in the opinion of the investigator may affect a study outcome variable;
  6. Are using any systemic or topical medications that in the opinion of the investigator may affect a study outcome variable;
  7. Have known sensitivity to the diagnostic pharmaceuticals to be used in the study;
  8. Have undergone refractive error surgery;
  9. Are a member of the Centre for Ocular Research & Education (CORE) directly involved in the study.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Double Blind

28 participants in 2 patient groups

Dailies Total1 Multifocal, ACUVUE OASYS MAX 1-Day Multifocal
Experimental group
Description:
Fit participant with Dailies Total1 Multifocal first, and with ACUVUE OASYS MAX 1-Day Multifocal second.
Treatment:
Device: Deleficon A (multifocal)
Device: Senofilcon A (multifocal)
ACUVUE OASYS MAX 1-Day Multifocal, Dailies Total1 Multifocal
Experimental group
Description:
Fit participant with ACUVUE OASYS MAX 1-Day Multifocal first, and with Dailies Total1 Multifocal second.
Treatment:
Device: Deleficon A (multifocal)
Device: Senofilcon A (multifocal)

Trial contacts and locations

1

Loading...

Central trial contact

Jill Woods, MSc, MCOptom

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems